Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.
Study Finds Vaccine Effectiveness Lowers as Time Increases From Last Dose
Protection against COVID-19 and vaccine effectiveness increased after receiving 1 or 2 booster doses compared with a primary series alone, but vaccine effectiveness generally declined as the time since last dose increased.
Chatbot Systems Using AI May Feasibly Provide Access to Information on Infectious Diseases
A recent study found that chatbot systems that used artificial intelligence (AI) could be valuable in providing access to current, accurate, and complete information about infectious diseases and vaccines against them.
ACCESS Tests Effect of Eliminating Co-pay on CV Outcomes
Braden Manns, MD, MSc, a nephrologist and health economics researcher at the University of Calgary in Canada, will present the results of a randomized trial evaluating the impact of removing co-payments for drugs that treat chronic conditions on cardiovascular outcomes during the American College of Cardiology Scientific Sessions in New Orleans, Louisiana, on Sunday, March 5.
How Community-Based Organizations Can Help Address Vaccine Disparities
A recent study found that understanding and engaging with community-based organizations could help public health officials and care providers disperse accurate information and address disparities surrounding COVID-19 and routine immunizations.
Dr Michael Cohen Discusses Accessibility of Future Gene Therapies
Michael N. Cohen, MD, FAAO, retinal surgeon at Wills Eye Hospital in Philadephia and Mid Atlantic Retina, speaks about the future of gene therapy and the accessibility and availability of these therapies moving forward.
Dr Amy Crawford-Faucher on Efforts to Get Childhood Immunizations Back on Track
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed the potential of a respiratory syncytial virus vaccine in children, as well as ongoing efforts to get childhood vaccination rates back on track.
Dr Amy Crawford-Faucher Discusses RSV and Future Vaccines
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed treatment of respiratory syncytial virus (RSV) without a vaccine and what a future vaccine could mean for older adults.
2 Commerce Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.